About Daytryp

Psychedelics alter how humans view themselves and their surroundings. There are three categories of possible psychedelic experiences: mystical, insightful, or challenging. A mystical experience is most easily understood as “a spiritual connection to the divine,” an insightful experience can increase a person’s awareness and understanding of themselves, and lastly, a challenging experience is one that heightens physical and emotional responses.

Psychedelic-assisted psychotherapy is providing needed options for debilitating mental-health disorders including PTSD, major depressive disorder, alcohol-use disorder, anorexia nervosa and more that kill thousands every year in the United States, and cost billions worldwide in lost productivity. We imagine a world where plant medicine, fungi and psychedelics are no longer criminalized, and are made affordable and accessible to people of all races, creeds and backgrounds.

Daytryp is HQ’d in Bend, Oregon, where plant medicines are decriminalized and will be legalized January 2023. We also have a Psychedelic Assisted Treatment Center in Phoenix, AZ where we offer Ketamine Assisted Psychotherapy (KAP) and will be participating in clinical trials using MDMA and Psilocybin for depression and substance abuse addiction. Psilocybin is legal in Jamaica and Brazil, and decriminalized in Colorado, California, Chicago, Michigan, DC, Oregon & Washington State, with many more states to come.

Welcome to the Future of Healing, Welcome to Daytryp Health.

MISSION: To support people dealing with mental health and anxiety challenges, as well as those with a desire to improve holistically, spiritually and mentally. It’s a responsibility Daytryp takes very seriously. If you are seeking to get high and “trip out” with friends, we are not for you.

The expansive healing powers of psychedelics mean our products and services have value and relevance to a wide range of customers. Our focus here is to serve clients searching for more mindful, expansive lives. Psychedelics offer a pathway to that sort of experience, psilocybin specifically.

We’re here to help you maximize every moment. Our Psychedelic treatment protocols are designed to boost focus, increase creativity, energize your every day and most importantly, make you smile more 🙂 Furthermore, we can help those inclined to depression, anxiety and substance abuse issues get back on their path to peace & happiness.

The Psychedelic Revolution is Now Here

As professionals and creatives, we were looking for solutions to help us focus and get our creative juices flowing. We stumbled onto the psychedelic space after 20 years of owning addiction and mental health organizations. We quickly learned about the benefits of microdosing psychedelics, particularly psilocybin and ketamine and realized that psychedelics is the new path forward in mental healthcare, in our opinion. Through countless research and testing, we created Daytryp, a psychedelically charged healthcare organization designed to help you think more clearly, alleviate depression, anxiety, PTSD, addiction AND increase your spiritual enlightenment.

The Elephant in the Room

Don’t worry. It’s a figurative elephant – you’re not tripping out. For a lot of new daytrypper’s, we understand your hesitation to try psychedelics. And why wouldn’t you? There’s still a social stigma and general misinformation around psychedelics that’s been fueled by misconceptions and irrational fears. We’re sure you have a lot of questions and we’re here to educate and advocate.

Backed by Science, Blessed by Shamans

The Daytryp experience is backed by scientific data proving the efficacy of psychedelics. Furthermore, and because of our deep respect and admiration for the indigenous people before us that have been using plant medicine and psychedelics for hundreds, if not thousands of years, we are shamanistic in our values. Medicinal psilocybin and other psychedelic plant medicines, specifically intended for those with mental health, addiction, PTSD, depression & anxiety issues, are those we cater to mostly; those who seek a deeper and more spiritual calling in their lives. At the current time, our sacred psychedelic offerings are Ketamine and we’ll be participating in clinical trials with psilocybin and MDMA. More to come once the world realizes that these plants and psychedelics hold the power to heal the world of PTSD, anxiety, addiction and depression.

Psychedelic Research

Evidence suggests that psychedelic drugs can be an effective treatment for PTSD, anxiety, obsessive-compulsive disorder, major depression & addiction — including cases that don’t respond to conventional antidepressants. A Johns Hopkins study and a concurrent New York University study found that about 80 percent of participants showed clinically significant decreases in depressed mood and anxiety even six months after receiving one to two psilocybin treatments.

Shaman Amy

Amy is a doctoral-level psychiatrist and a certified Shaman living in Bend, Oregon. As a mental health professional, Amy assists clients by providing Psychedelic Assisted Treatment &, Psilocybin (medication) management, medical mushroom coaching, and more. Amy has seen first hand the positive benefits of Psilocybin and always prefers the Psychedelic Assisted Treatment route over Western Medicine techniques.

Shaman Ella

In 2007, Ella became the first person in the USA to be legally given a psychedelic in 40 years, as a volunteer in the study of the neural correlates of a psychedelic experience. These studies are revealing how Psilocybin seems to reduce activity in key connector hubs of the brain, those that might have a role in constructs of ego and self-identity, to allow a state of unrestrained cognition and enhanced memory recall. Similar research is delving into spiritual experiences as potentially important in the psychic changes that can be catalysed by psychedelic agents. Ella enthusiastically progresses her account of the potential of psychedelic drugs into spirituality and creativity, bringing his unique clinical background to consider concepts too often neglected in psychiatric illness.